. Are lecanemab and donanemab disease-modifying therapies?. Alzheimers Dement. 2024 Sep;20(9):6659-6661. Epub 2024 Aug 3 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.